Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Bristol-Myers Squibb: Well Defined Strategy Catalyst For Success
Seeking Alpha
Thursday, January 12, 2012 - 9:08am
tags:
Bristol-Myers Squibb
For Theravance Investors, GlaxoSmithKline Won't Be The Answer
Seeking Alpha
Thursday, January 12, 2012 - 8:30am
tags:
Theravance, GSK, Relovair
Gilead nears completion of Pharmasset deal
Yahoo/AP
Thursday, January 12, 2012 - 8:29am
tags:
M&A, Pharmasset, Gilead
Pradaxa Side Effect Reports Were Hemorrhaging
Pharmalot
Wednesday, January 11, 2012 - 1:04pm
tags:
Pradaxa, Boehringer Ingelheim
$3B or less is Big Pharma's M&A sweet spot
Fierce Pharma
Wednesday, January 11, 2012 - 12:58pm
tags:
M&A, Roche, Sanofi, Bristol-Myers Squibb, Novartis, Pfizer, Merck
Human Genome jumps 12% in midday trading
Marketwatch
Wednesday, January 11, 2012 - 12:54pm
tags:
Human Genome Sciences, Benlysta
Theravance shares make modest rebound
Marketwatch
Wednesday, January 11, 2012 - 12:38pm
tags:
Theravance, Relovair
Teva Gets Upgrade on Revenue Growth
TheStreet.com
Wednesday, January 11, 2012 - 12:00pm
tags:
Teva Pharmaceuticals
Cubist's Preliminary Sales Impress
Yahoo/Zacks.com
Wednesday, January 11, 2012 - 11:59am
tags:
Cubist Pharmaceuticals
Analyst gauges financial loss from Novartis recall
Yahoo/AP
Wednesday, January 11, 2012 - 11:55am
tags:
Novartis, recalls
Can These 5 Pharma Stocks Keep Paying Big Dividends?
Seeking Alpha
Wednesday, January 11, 2012 - 11:55am
tags:
Abbott Laboratories, GSK, Eli Lilly, Merck, Pfizer
A Conflicted FDA Panel, Bayer & Birth Control Pills
Pharmalot
Wednesday, January 11, 2012 - 10:59am
tags:
FDA, Yaz, Yasmin, birth control pill, Bayer
Celldex Therapeutics: A Potential Triple With Data On The Way
Seeking Alpha
Wednesday, January 11, 2012 - 10:58am
tags:
Celldex, Amgen, Bristol-Myers Squibb, Dendreon, Seattle Genetics, Exelixis
Against The Grain: Abbott Is Not Worth Your Money Now
Seeking Alpha
Wednesday, January 11, 2012 - 10:57am
tags:
Abbott Laboratories, Eli Lilly, Merck, Pfizer
Dendreon posied to get decent mark from German regulator, says RBC Capital
The Fly on the Wall
Wednesday, January 11, 2012 - 10:56am
tags:
Dendreon, Germany
Yield Chasers: Pfizer's 4% Dividend Is Very Appealing
Seeking Alpha
Wednesday, January 11, 2012 - 10:55am
tags:
Pfizer, dividends
Sanofi CEO Is Open to Deals of Up to $2.6 Billion This Year
Bloomberg
Wednesday, January 11, 2012 - 10:55am
tags:
Sanofi, Pharma CEOs, M&A, Chris Viehbacher
2012 Preview: Merck
Motley Fool
Wednesday, January 11, 2012 - 10:54am
tags:
Merck
Life Tech, Illumina unveil one-day genomes
Marketwatch
Tuesday, January 10, 2012 - 6:05pm
tags:
Life Technologies, Illumina, genomes
Arena says FDA accepts new filing for obesity drug lorcaserin, will make decision by June 27
Yahoo/AP
Tuesday, January 10, 2012 - 6:04pm
tags:
Arena, FDA, obesity, lorcaserin

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.